U.K. regulator accepts Humanigen’s COVID drug for speedy review, as analysts spell out reasons to be hopeful for FDA nod
U.K. regulator accepts Humanigen’s COVID drug for speedy review, as [...]
U.K. regulator accepts Humanigen’s COVID drug for speedy review, as [...]
Britain bets on biotech as billions set to boost life [...]
Muna raises $73M to go after Alzheimer’s, Parkinson’s and MS [...]
Large differences in phase 3 overall survival spark FDA hold [...]
Elevation raises $65M to turn serial failure into tumor-agnostic success [...]
Pfizer passes COVID-19 vaccine safety milestone, reveals 95% efficacy ahead [...]
Metabolic signaling points to new targets in autoimmune diseases aliu [...]